Meeri Kim


Cell-Based Therapies May ‘Level the Playing Field’ in Non-Small Cell Lung Cancer

April 20, 2021

Even with all the recent advances in targeted therapies and immunotherapy drugs, patients with non-small cell lung cancer still need more treatment options. Although it’s early, cell-based therapies have shown some promise, with more research underway.

The Logistics of Multigene Panel Testing in Breast Cancer

October 22, 2017

Generally, health insurance covers the cost of genetic testing recommended by a physician. However, some patients who had BRCA testing in the past have had trouble getting reimbursed for a follow-up panel test. The outof- pocket cost for a single panel test can be up to $5,000, although lower-cost tests are available.